RecruitingNot Applicable

TQ-PAL Development and Validation

Ireland200 participantsStarted 2023-09-01

Plain-language summary

Taste problems are common among patients with advanced cancer. These symptoms can affect the pleasure of eating and drinking, reduce dietary intake, cause low mood, and a lower quality of life. There is no validated tool to assess taste disturbances and their impact on patients with advanced cancer. This study will develop and validate a novel assessment tool to assess taste disturbances and their impact on patients with advanced cancer.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: 18 years of age Diagnosis of locally advanced or metastatic cancer Referred to palliative care/oncology services Taste problems rated 'moderate' or worse over previous 2-week period Good understanding of English Exclusion Criteria: Cognitive impairment (unable to provide consent / complete questionnaire) Taste problems precedes cancer diagnosis. Head and neck surgery Head and neck radiotherapy Salivary gland disorders (e.g., Sjogren's Syndrome) In the 'Deteriorating' or 'Terminal' Phase of illness

What they're measuring

To develop a novel assessment tool to assess taste disturbances in patients with advanced cancer

Timeframe: December 2025

To validate the newly developed Taste Questionnaire in Palliative Care (TQ-PAL)

Timeframe: December 2025

Trial details

NCT IDNCT06588933

SponsorProf Andrew Davies

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-31

Contact for this trial

Andrew Davies, FRCP

014986235 andavies@tcd.ie

View on ClinicalTrials.gov More Altered Taste trials